Skip to Content

Mylan, Pfizer Settle Patent Lawsuit With Two Others

BRIEF: Mylan, Pfizer settle patent lawsuit with two others [The Pittsburgh Tribune-Review]

From Pittsburgh Tribune-Review (PA) (February 17, 2012)

Feb. 17--Mylan Inc. said on Thursday that it and Pfizer Inc. had reached a settlement with two companies that want to make a generic version of Mylan's EpiPen.

EpiPen, used to treat severe allergic reactions, is manufactured for Canonsburg-based Mylan by a Pfizer subsidiary, Meridian Medical Technologies. The companies settled a patent infringement lawsuit with Intelliject and Sanofi-Aventis over Intelliject's e-cue product, which is an epinephrine auto-injector like EpiPen, Mylan said.

Under the settlement, Intelliject's e-cue, which will be manufactured and sold by Sanofi-Aventis, may not be introduced on the U.S. market before Nov. 15, pending approval by the Food and Drug Administration.


(c)2012 The Pittsburgh Tribune-Review (Greensburg, Pa.)

Visit The Pittsburgh Tribune-Review (Greensburg, Pa.) at

Distributed by MCT Information Services

Posted: February 2012